Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.64%
1,047.36
+6.67
+0.64%
1,040.691,048.261,057.851,043.30
SIXC
Communications
SIXC
Communications
SIXC
+1.04%
566.19
+5.83
+1.04%
560.36560.36568.72560.36
SIXE
Energy
SIXE
Energy
SIXE
-0.47%
1,311.54
-6.15
-0.47%
1,317.691,324.291,335.361,309.90
SIXI
Industrials
SIXI
Industrials
SIXI
-1.36%
1,585.09
-21.82
-1.36%
1,606.911,611.511,621.751,583.36
SIXM
Financials
SIXM
Financials
SIXM
+1.23%
597.55
+7.27
+1.23%
590.28592.25601.18592.25
SIXR
Staples
SIXR
Staples
SIXR
+0.46%
831.77
+3.79
+0.46%
827.98828.20835.94826.74
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.83%
198.68
+1.64
+0.83%
197.04197.04200.54197.04
SIXT
Technology
SIXT
Technology
SIXT
-1.72%
2,573.07
-45.13
-1.72%
2,618.202,638.492,649.452,569.91
SIXU
Utilities
SIXU
Utilities
SIXU
+0.86%
932.59
+7.93
+0.86%
924.66929.51938.99929.51
SIXV
Health care
SIXV
Health care
SIXV
+0.47%
1,456.35
+6.76
+0.47%
1,449.591,453.441,462.731,452.88
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.18%
2,140.72
+3.83
+0.18%
2,136.892,149.922,166.642,139.01
SUPN:NASDAQ
Supernus Pharmaceuticals Inc
$49.27
-0.50%
(-0.25) 1D
Mar 30, 2:14:15 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SUPN...
Open
$49.88
High
$50.07
Low
$48.85
Mkt. cap
2.84B
Avg. vol.
803.70K
Volume
210.93K
52-wk high
$59.68
52-wk low
$29.16
EPS
-$0.68
Beta
0.70
Shares outstanding
57.58M
No. of employees
778
News stories
From sources across the web
About Supernus Pharmaceuticals Inc
CEOJack A. Khattar
Employees778
Founded2005
HeadquartersRockville, Maryland, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
149.82M
165.45M
192.10M
211.57M
Cost of goods sold
15.76M
16.83M
48.33M
-55.40M
Cost of revenue
15.76M
16.83M
48.33M
-55.40M
Research and development expenses
26.93M
22.12M
-
106.24M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
94.34M
94.55M
110.97M
197.36M
Operating expense
141.06M
137.48M
135.30M
328.12M
Total operating expenses
156.82M
154.31M
183.63M
272.72M
Operating income
-7.00M
11.14M
8.48M
-61.15M
Other non operating income
-
-
-
-
EBT including unusual items
-5.83M
16.67M
-57.95M
-1.91M
EBT excluding unusual items
-2.57M
15.67M
10.75M
-58.69M
Income tax expense
6.00M
-5.83M
-12.84M
2.19M
Effective tax rate
-102.83%
-34.98%
22.15%
-114.47%
Other operating expenses
-
-
-
-
Net income
-11.83M
22.50M
-45.12M
-4.10M
Net profit margin
-7.89%
13.60%
-23.49%
-1.94%
Earnings per share
0.44
0.91
0.61
0.88
Interest and investment income
4.42M
4.53M
2.28M
2.46M
Interest expense
-
-
-
-
Net interest expenses
4.42M
4.53M
2.28M
2.46M
Depreciation and amortization charges
-
-
-
-
EBITDA
13.39M
32.50M
33.28M
-36.14M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more